atepeq/tico19 huggingface dataset:
Coronaviruses belong to the family of Coronaviridae, order Nidovirales, and realm Riboviria.
Obuwuka bwa Coronaviruse bugwa mu kika kya Coronaviridae, omutuba (order) Nidovirales, ne realm Riboviria.
Genus Betacoronavirus; type species: Murine coronavirus
Mu ssiga (Genus) Betacoronavirus; mu lunyiriri (species): Murine coronavirus
Species: Betacoronavirus 1 (Bovine Coronavirus, Human coronavirus OC43), Human coronavirus HKU1, Murine coronavirus, Pipistrellus bat coronavirus HKU5, Rousettus bat coronavirus HKU9, Severe acute respiratory syndrome-related coronavirus (SARS-CoV, SARS-CoV-2), Tylonycteris bat coronavirus HKU4, Middle East respiratory syndrome-related coronavirus, Hedgehog coronavirus 1 (EriCoV)
Olunyiriri: Betacoronavirus 1 (Bovine Coronavirus, Human coronavirus OC43), Human coronavirus HKU1, Murine coronavirus, Pipistrellus bat coronavirus HKU5, Rousettus bat coronavirus HKU9, Severe acute respiratory syndrome-related coronavirus (SARS-CoV, SARS-CoV-2), Tylonycteris bat coronavirus HKU4, Middle East respiratory syndrome-related coronavirus, Hedgehog coronavirus 1 (EriCoV)
Species: Beluga whale coronavirus SW1, Infectious bronchitis virus
Olunyiriri: Beluga whale coronavirus SW1, Infectious bronchitis virus
The most recent common ancestor (MRCA) of all coronaviruses is estimated to have existed as recently as 8000 BCE, although some models place the common ancestor as far back as 55 million years or more, implying long term coevolution with bat and avian species.
Jjajja wa coronavirus eyaakasembyeyo (MRCA) owa coronaviruses zonna ateeberezebwa okuba nga yaliwo mu mwaka gwa 8000 BCE, wadde ng’okunoonyereza okumu kulaga nti jjajja oyo owawamu yaliwo mabega ddala eyo emyaka miliyoni 55 oba n’okusingawo, kino nga kitegeeza nti bukyusekyuse nnyo wamu n’akawundo n’olunyiriri lwa avian.
The most recent common ancestor of the alphacoronavirus line has been placed at about 2400 BCE, the betacoronavirus line at 3300 BCE, the gammacoronavirus line at 2800 BCE, and the deltacoronavirus line at about 3000 BCE.
Jjajja w’oluse lwa alphacoronavirus eyaakasembyeyo ateeberezebwa eyo mu mwaka gwa 2400 BCE, oluse lwa betacoronavirus luteeberezebwa eyo mu mwaka gwa 3300 BCE, oluse lwa gammacoronavirus mwaka gwa 2800 BCE, ate n’oluse lwa deltacoronavirus awo nga mu 3000 BCE.
The large number of host bat and avian species, and their global range, has enabled extensive evolution and dissemination of coronaviruses.Many human coronavirus have their origin in bats.
Omuwendo gw’obuwundo obubeerako obuwuka n’olunyiriri lwa avian, n’enjawulo ezibirimu mu nsi yonna bisobozesezza enfuukafuuka ey’amaanyi n’okusaasaana kwa coronaviruses. Human Coronavirus nnyingi zisibuka mu buwundo.
More recently, alpaca coronavirus and human coronavirus 229E diverged sometime before 1960.
Emabegako awo, alpaca coronavirus ne human coronavirus 229E zaawukana ng’omwaka gwa 1960 tegunnaba.
MERS-CoV emerged in humans from bats through the intermediate host of camels.
MERS-CoV kaalabikira mu bantu kava mu bwundo nga kayitira mu kibeerako obuwuka ekitasaanasaanya, eŋŋamiya.
MERS-CoV, although related to several bat coronavirus species, appears to have diverged from these several centuries ago.
MERS-CoV, newankubadde nga kalina Oluganda ku lunyiriri lwa bat coronavirus species, kafaanana okuba nga kaawukana ku byasa bingi emabegako ddala.
The most closely related bat coronavirus and SARS-CoV diverged in 1986.
Bat coronavirus akasinga okuba n’oluganda olw’okumpi ennyo ke ka SARS-CoV akaafuuka mu 1986.
A possible path of evolution, of SARS coronavirus and keen bat coronaviruses, suggests that SARS related coronaviruses coevolved in bats for a long time.
Omuyitiro gw’okufuukafuuka ogusoboka ogwa SARS coronavirus ne keen bat coronaviruses, gulaga nti obuwuka obwekwanya ku SARS bwafuukirafuukira mu buwundo okumala ebbanga ddene.
In the 1790s, equine coronavirus diverged from the bovine coronavirus after a cross-species jump.
Mu myaka gya 1790, equine coronavirus yafuuka okuva mu bovine coronavirus oluvannyuma lw’okubuuka amacco olunyriri (cross-species jump).
Later in the 1890s, human coronavirus OC43 diverged from bovine coronavirus after another cross-species spillover event.
Oluvannyuma mu myaka gya 1890, human coronavirus OC43 yafuuka okuva mu bovine coronavirus oluvannyuma lw’okubuuka okuva mu lunyiriri omulundi omulala.
It is speculated that the flu pandemic of 1890 may have been caused by this spillover event, and not by the influenza virus, because of the related timing, neurological symptoms, and unknown causative agent of the pandemic.
Kiteeberezebwa nti nawookeera wa ssenyiga owa 1890 ayinza okuba nga yava mu kubuuka kw’akawuka okwo, so si kuleetebwa kawuka ka yegu (influenza virus), olw’okukwatagana mu budde, obubonero bw’emisiwa n’ebirala ebitamanyiddwa ebyavaako nawookeera.
Human coronavirus OC43 besides causing respiratory infections is also suspected of playing a role in neurological diseases.
Human coronavirus OC43 ng’oggyeeko okuba nga kavaako okulwala kw’omussizo era kateeberezebwa okuba nga kazannya ekifo mu ndwadde z’emisiwa.
In the 1950s, the human coronavirus OC43 began to diverge into its present genotypes.
Mu myaka gya 1950, human coronavirus OC43 kaatandika okufuuka nga koolekera genotypes ze kalina kati.
Phylogentically, mouse hepatitis virus (Murine coronavirus), which infects the mouse's liver and the central nervous system, is related to human coronavirus OC43 and bovine coronavirus.
Mu ngeir y’obuwuka obuleeta endwadde, mouse hepatitis virus (Murine coronavirus), akakwataka ekibumba ky’emmese n’omuyungiro gw’emisiwa, kalina Oluganda ku human coronavirus OC43 ne bovine coronavirus.
Human coronavirus HKU1, like the aforementioned viruses, also has its origins in rodents.
Akawuka ka Human coronavirus HKU1, era ng’obuwuka obwogeddwako waggulu, nako kasibuka mu mmese.
Coronaviruses vary significantly in risk factor.
Obuwuka bwa Coronaviruses bwawukanira ddala mu ngeri gye bukosaamu.
Some can kill more than 30% of those infected, such as MERS-CoV, and some are relatively harmless, such as the common cold.
Obumu busobola okutta abantu abasoba mu 30 ku kikumi ku abo abakwatiddwa, okugeza nga MERS-COV, ate obulala tebulina bulabe bwa maanyi, okugeza nga sennyiga owa bulijjo.
Coronaviruses can cause colds with major symptoms, such as fever, and a sore throat from swollen adenoids.
Obuwuka bwa Coronaviruses busobola okulwaza sennyiga n’obubonero obw’amaanyi, okugeza nga olusujjasujja, n’amabwa mu mimiro nga kiva ku kuzimba adenoids.
Coronaviruses can cause pneumonia (either direct viral pneumonia or secondary bacterial pneumonia) and bronchitis (either direct viral bronchitis or secondary bacterial bronchitis).
Obuwuka bwa Coronaviruses busobola okulwaza lubyamira (nga omufuna butereevu oba nga akusiigibwa) n’okulwala amawugwe (ng’ofunye akawuka butereevu oba nga kakusiigiddwa).
The human coronavirus discovered in 2003, SARS-CoV, which causes severe acute respiratory syndrome (SARS), has a unique pathogenesis because it causes both upper and lower respiratory tract infections.Six species of human coronaviruses are known, with one species subdivided into two different strains, making seven strains of human coronaviruses altogether.
Human coronavirus kaazuulibwa mu 2003, SARS-CoV, akaleeta severe acute respiratory syndrome (SARS), bulina endwadde ze buleeta ez’enjawulo kubanga buleeta obuzibu mu mussizo ogwa waggulu n’ogwa wansi. Ennyiriri mukaagaa eza human coronaviruses zimanyiddwa ng’olunyiriri olumu lweyawuddemu ebika bibiri, ebikola ebika musanvu ebya human coronaviruses byonna awamu.
Four of these coronaviruses continually circulate in the human population and produce the generally mild symptoms of the common cold in adults and children worldwide: -OC43, -HKU1, HCoV-229E, -NL63.
Coronavirus nnya ku ezo zeeyongera okusaasaana mu bantu era ne zireeta obubonero obutonotono nga ssenyigo owa bulijjo mu nsi yonna mu bakulu n’abanto: -OC43, -HKU1, HCoV-229E, -NL63.
Coronaviruses cause about 15% of commons colds.
Coronavirus zireeta ebitundu nga 15% ebyassenyiga owa bulijjo.
The majority of colds are caused by rhinoviruses.
Ssenyiga asinga aleetebwa.
The four mild coronaviruses have a seasonal incidence occurring in the winter months in temperate climates.
Obuwuka obutali bwa maanyi obuna bulina ekiseera we bulabikira, mu bitundu ebyobunnyogovu bulabikira mu myezi egy’obunnyogovu.
There is no preference towards a particular season in tropical climates.
Ate mu bitundu ebyebbugumu, tewali kiseera kye businga kwagala.
Four human coronaviruses produce symptoms that are generally mild:
Okutwaliza awamu, obuwuka bwa human coronavirus buleeta obubonero butali bwa maanyi:
The virus was officially named the SARS coronavirus (SARS-CoV).
Akawuka ako kaatuumibwa SARS coronavirus (SARS-CoV) mu butongole.
More than 8,000 people were infected, about ten percent of whom died.
Abantu abasukka mu 8,000 baalwala era ebitundu kkumi ku kikumi ku bo ne baafa.
In September 2012, a new type of coronavirus was identified, initially called Novel Coronavirus 2012, and now officially named Middle East respiratory syndrome coronavirus (MERS-CoV).
Mu Gwomwenda 2012, akawuka akapya aka coronavirus kaalabibwa, mu kusooka kaayitibwa Novel Coronavirus 2012, naye kati mu butongole kaatumibwa Middle East respiratory syndrome coronavirus (MERS-CoV).
The World Health Organization issued a global alert soon after.
Ekitongole ky’Ensi yonna eky’Ebyobulamu (WHO) mangu ago kyafulumya okulabula.
The WHO update on 28 September 2012 said the virus did not seem to pass easily from person to person.
Amawulire ga WHO amapya nga 28 Ogwomwenda 2012 gaagamba nti akawuka kalabika tekatambula mangu kuva ku muntu omu kudda ku mulala.
However, on 12 May 2013, a case of human-to-human transmission in France was confirmed by the French Ministry of Social Affairs and Health.
Wabula, nga 12 Ogwokutaanu 2013, mu Bufalansa waalabikawo okusaasaana kw’akawuka kano nga kava ku muntu omu okudda ku mulala era kino kyakakasibwa Ministule ya Bufalansa ey’Ebyobulamu eyitibwa French Ministry of Social Affairs and Health.
In addition, cases of human-to-human transmission were reported by the Ministry of Health in Tunisia.
Mu ngeri y’emu, okusiiga okuva ku muntu omu okudda ku mulala kwalabika mu Tunisia era ekitongole ky’Ebyobulamu mu Tunisia ne kitegeeza bwe kityo.
Two confirmed cases involved people who seemed to have caught the disease from their late father, who became ill after a visit to Qatar and Saudi Arabia.
Abalwadde ababiri abaakakasibwa baali bantu babiri abaalabika ng’obulwadde obwo baabuggya ku kitaabwe eyaafa, eyalwala ng’avudde mu lugendo lwe yaliko mu Qatar ne Saudi Arabia.
Despite this, it appears the virus had trouble spreading from human to human, as most individuals who are infected do not transmit the virus.
Wadde ng’ekyo kyaliwo, kirabika nti akawuka kaalina obuzibu okusaasaana okuva ku muntu omu okudda ku mulala, kubanga abantu abamu abalwala tebasiiga balala kawuka ako.
The final name for the virus is Middle East respiratory syndrome coronavirus (MERS-CoV).
Erinnya ly’akawuka erikakasiddwa lye lya Middle East respiratory syndrome coronavirus (MERS-CoV).
The only U.S. cases (both survived) were recorded in May 2014.In May 2015, an outbreak of MERS-CoV occurred in the Republic of Korea, when a man who had traveled to the Middle East, visited four hospitals in the Seoul area to treat his illness.
Abalwadde bokka abaali mu Amerika (bombi baawona) baalabibwa muGwakutaanu 2014. Mu Gwokutaanu 2015, okubalukawo kwa MERS-CoV kwagwawo mu Korea, omusajja eyali agenzeeko mu Middle East, yagenda okujjanjabibwa mu malwaliro ana mu kitundu ky’e Seoul.
This caused one of the largest outbreaks of MERS-CoV outside the Middle East.
Kino kyaleetawo okubalukawo kw’obulwadde bwa MERS-CoV, okumu ku okwo okukyasinze okuba okw’amaanyi ebweru wa Middle East.
As of December 2019, 2,468 cases of MERS-CoV infection had been confirmed by laboratory tests, 851 of which were fatal, a mortality rate of approximately 34.5%.
Mu Deesemba 2019, abalwadde 2,468 ba MERS-CoV baakakasibwa n’okukebera mu magezeserezo, abalwadde 851 baafa, bye 34.5% ku balwadde abo.
In December 2019, a pneumonia outbreak was reported in Wuhan, China.
Mu Deesemba 2019, lubyamira yabalukawo mu Wuhan, China era amawulire ne gafuluma.
On 31 December 2019, the outbreak was traced to a novel strain of coronavirus, which was given the interim name 2019-nCoV by the World Health Organization (WHO), later renamed SARS-CoV-2 by the International Committee on Taxonomy of Viruses.
Nga 31 Deesemba 2019, obulwadde obwo bwalondoolwa ne bukwanyizibwa ku bulwadde bwa coronavirus obwaliwo awo mu kitundu, era mu kiseera WHO ne kibuwa erinnya ery’ekiseera 2019-nCoV, oluvannyuma Akakiiko k’Ensi yonna Akanoonyereza ku Buwuka, International Committee on Taxonomy of Viruses ne babutuuma SARS-CoV-2.
Some researchers have suggested the Huanan Seafood Wholesale Market may not be the original source of viral transmission to humans.As of 17 April 2020, there have been at least 153,822 confirmed deaths and more than 2,240,191 confirmed cases in the coronavirus pneumonia pandemic.
Abanoonyereza abamu balowooza nti akatale k’emmere akayitibwa Huanan Seafood Wholesale Market kayinza okuba nga si ye nsibuko y’okusaasaana kw’akawuka mu bantu. Olwa 17 Ogwokuna 2020 we lwatuukira, waakiri abantu nga 153,822 baali bafudde era n’abalwadde ba nawookeera wa lubyamula nga baweze 2,240,191.
The Wuhan strain has been identified as a new strain of Betacoronavirus from group 2B with approximately 70% genetic similarity to the SARS-CoV.
Obulwadde bw’omu Wuhan bulabiddwa nga ng’obulwadde obupya obwa Betacoronavirus okuva mu kibinja 2B ng’ebitundu kumpi 70% eby’endagabutonde bifaanana ne SARS-CoV.
The virus has a 96% similarity to a bat coronavirus, so it is widely suspected to originate from bats as well.
Akawuka kafaanana ne bat coronavirus ebitundu 96%,bwe katyo kateeberezebwa okuba nga nako kaava mu buwundo.
The pandemic has resulted in travel restrictions and nationwide lockdowns in several countries.
Nawookeera aleeseewo okukugirwa mu ntambula wamu n’emiggalo egisaanira eggwanga eddamba mu mawanga mangi mu nsi.
Coronaviruses have been recognized as causing pathological conditions in veterinary medicine since the 1930s.
Coronavirus zirabiddwa ng’ezireeta obulwadde mu nsolo okuva mu myaka gya 1930.
Except for avian infectious bronchitis, the major related diseases have mainly an intestinal location.
Ng’oggyeeko obulwadde bwa avian infectious bronchitis, obulwadde obukulu obwefaanaanyiriza okusinga bubeera mu byenda.
Coronaviruses primarily infect the upper respiratory and gastrointestinal tract of mammals and birds.
Okusinga ennyo Coronavirus zikwata kitundu kya mussizo ekyawaggulu mu nsolo ne mu binyonyi.
They also cause a range of diseases in farm animals and domesticated pets, some of which can be serious and are a threat to the farming industry.
Era zireeta n’obulwadde obw’enjawulo mu nsolo ezirundibwa n’obusolo obuzannyisibwa obubeera ewaka, obulwadde obwo obumu busobola okubeera obw’amaanyi era ne bukaluubiriza n’omulimu gw’obulunzi.
In chickens, the infectious bronchitis virus (IBV), a coronavirus, targets not only the respiratory tract but also the urogenital tract.
Mu nkoko, akawuka kano infectious bronchitis virus (IBV), ak’ekika kya coronavirus, tekalumba mussizo gwokka wabula n’omuyitiro gw’omusulo (urogenital tract).
The virus can spread to different organs throughout the chicken.
Akawuka kasobola okusaasaanira mu bitundu by’enkoko eby’enjawulo.
Economically significant coronaviruses of farm animals include porcine coronavirus (transmissible gastroenteritis coronavirus, TGE) and bovine coronavirus, which both result in diarrhea in young animals.
Mu byenfuna, obuwuka bu-coronavirus obulumba ensolo z’omu malundiro mulimu porcine coronavirus (transmissible gastroenteritis coronavirus, TGE) ne bovine coronavirus, obuwuka bwombi obwo buleeta ekiddukano mu nsolo ento.
Feline coronavirus: two forms, feline enteric coronavirus is a pathogen of minor clinical significance, but spontaneous mutation of this virus can result in feline infectious peritonitis (FIP), a disease associated with high mortality.
Feline coronavirus: karimu enkula za mirundi ebiri, feline enteric coronavirus kawuka akaleeta obulwadde akatatiisa nnyo, naye akasolo kano bwe kazaalukana ennyo kasobola okuleeta obulwadde obuyitibwa infectious peritonitis (FIP), obulwadde buno butta nnyo.
Similarly, there are two types of coronavirus that infect ferrets: Ferret enteric coronavirus causes a gastrointestinal syndrome known as epizootic catarrhal enteritis (ECE), and a more lethal systemic version of the virus (like FIP in cats) known as ferret systemic coronavirus (FSC).
Mu ngeri y’emu, waliwo ebika bya coronavirus bibiri ebikosat ferret: Ferret enteric coronavirus kalwaza ebyenda (gastrointestinal syndrome) era obulwadde buno buyitibwa epizootic catarrhal enteritis (ECE), ate kyo ekika ky’akawuka kano ekisinga okuba eky’obulabe (gamba nga FIP mu mmese) kiyitibwa ferret systemic coronavirus (FSC).
There are two types of canine coronavirus (CCoV), one that causes mild gastrointestinal disease and one that has been found to cause respiratory disease.
Waliwo ebika bibiri ebya canine coronavirus (CCoV), akamu kaleeta obulwadde obuyitibwa mild gastrointestinal n’akalala akazuuliddwa nga kaleeta obulwadde mu mussizo.
Mouse hepatitis virus (MHV) is a coronavirus that causes an epidemic murine illness with high mortality, especially among colonies of laboratory mice.
Mouse hepatitis virus (MHV) kika kya coronavirus akaleeta epidemic murine illness, obulwadde buno butta okukamala, naddala mu Magana ga mususu ow’omu magezeserezo.
Sialodacryoadenitis virus (SDAV) is highly infectious coronavirus of laboratory rats, which can be transmitted between individuals by direct contact and indirectly by aerosol.
Sialodacryoadenitis virus (SDAV) ko kawuka akaleeta ennyo obulwadde mu mmese z’omu ggezeserezo, obulwadde obwo busobola okusaasaanyizibwa abantu kinnoomu nga bakwataganye butereevu ate n’obutali butereevu okuyitira mu nnyindo (aerosol).
Some strains of MHV cause a progressive demyelinating encephalitis in mice which has been used as a murine model for multiple sclerosis.
Obulwadde obumu obwa MHV buleeta progressive demyelinating encephalitis mu mususu akozeseddwa ng’ageraageranyizibwako (murine model) mu multiple sclerosis.
Significant research efforts have been focused on elucidating the viral pathogenesis of these animal coronaviruses, especially by virologists interested in veterinary and zoonotic diseases.
Kaweefube w’okunoonyereza awerako ateereddwa mu kwongera okunnyonnyola enkula y’akawuka ak’omu nsolo (animal coronaviruses), naddala abanoonyereza ku buwuka abanoonyereza ku ntambula y’obulwadde okuva mu nsolo okudda mu bantu.
Porcine coronavirus (transmissible gastroenteritis coronavirus of pigs, TGEV).
Akawukaka ka Porcine coronavirus (transmissible gastroenteritis coronavirus ow’omu mbizzi, TGEV).
Bovine coronavirus (BCV), responsible for severe profuse enteritis in of young calves.
Akawuka ka Bovine coronavirus (BCV), akasaasaanya severe profuse enteritis mu nnyana.
Feline coronavirus (FCoV) causes mild enteritis in cats as well as severe Feline infectious peritonitis (other variants of the same virus).
Akawuka ka Feline coronavirus (FCoV) kaleeta mild enteritis mu kkapa wamu ne mu severe Feline infectious peritonitis (ebika by’akawuka ako ebirala).
the two types of canine coronavirus (CCoV) (one causing enteritis, the other found in respiratory diseases).
ebika bya canine coronavirus (CCoV) ebibiri (ekimu nga kireeta enteritis, ate ekirala kisangibwa mu bulwadde bw’omussizo).
Turkey coronavirus (TCV) causes enteritis in turkeys.
Akawuka ka Turkey coronavirus (TCV) kaleeta enteritis mu ssekkoko.
Ferret enteric coronavirus causes epizootic catarrhal enteritis in ferrets.
Akawuka ka Ferret enteric coronavirus kaleeta epizootic catarrhal enteritis mu busolo obufaananako kkapa (ferrets).
Ferret systemic coronavirus causes FIP-like systemic syndrome in ferrets.
Akawuka ka Ferret systemic coronavirus kaleeta FIP-like systemic syndrome busolo obufaananako kkapa (ferrets).
Rabbit enteric coronavirus causes acute gastrointestinal disease and diarrhea in young European rabbits.
Akawuka ka Rabbit enteric coronavirus kaleeta acute gastrointestinal disease n’ekiddukano mu bumyu bw’e Bungereza obuto.
Porcine epidemic diarrhea virus (PED or PEDV), has emerged around the world.
Akakawuka ka Porcine epidemic diarrhea virus (PED oba PEDV), kabuluseewo mu nsi yonna.
b'Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Obukwadde bwa b'Coronavirus disease 2019 (COVID-19) bulwadde obusiigibwa obuleetebwa severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Common symptoms include fever, cough, and shortness of breath.
Mu bubonero obusinga okulabika mulimu omusujja, okukolola, n’okubaka omukka.
Other symptoms may include fatigue, muscle pain, diarrhea, sore throat, loss of smell, and abdominal pain.
Obubonero obulala mulimu kimenyoomenyo, obulumi mu binywa, embiro, amabwa mu mimiro, okulemererwa okuwunyiriza, n’okulumizibwa mu lubuto.
The time from exposure to onset of symptoms is typically around five days but may range from two to fourteen days.
Ebbanga okuva lwe bukwata omuntu okutuuka ku kiseera w’alabikirako obubonero litera kubeera awo mu nnaku ttaanu naye nga ziyinza okukyuka ne ziba wakati w’ennaku bbiri n’ekkumi na nnya.
While the majority of cases result in mild symptoms, some progress to viral pneumonia and multi-organ failure.
Weewaawo abalwadde abasinga beeyolekerako obubonero obutali bwa maanyi abamu bafuniramu ddala lubyamira n’ebitundu by’omubiriebimu ne biremererwa.
As of 17 April 2020, more than 2.24 million cases have been reported across 210 countries and territories, resulting in more than 153,000 deaths.
Olwa 17 Ogwokuna 2020 we lwatuukira, abalwadde abasukka mu bukadde 2.24 be bategeerekese mu mawanga n’ebitundu 210 era nga mu bo 153,000 bafudde.
More than 568,000 people have recovered.The virus is primarily spread between people during close contact, often via small droplets produced by coughing, sneezing, or talking.
Abantu abasukka 568,000 bawonye. Okusinga ennyo akawuka kasaasaanira mu bantu abasembereganye ennyo, naddala nga buyitira mu luzzizzi olujja omuntu ng’akolodde, ng’akubye omwasi, oba mu kwogera.
While these droplets are produced when breathing out, they usually fall to the ground or onto surfaces rather than being infectious over long distances.
Weewaawo oluzzizzi lufuluma omuntu ng’assizza omukka, lutera okugwa ku ttaka oba ku bintu, so tebukwata bantu beesudde bbanga ddene.
People may also become infected by touching a contaminated surface and then touching their eyes, nose, or mouth.
Abantu era basobola okukatibwa obulwadde nga bakutte ku kifo ekiriko obuwuka ate olwo ne beekwata mu maaso, mu nnyindo, oba ku mimwa.
The virus can survive on surfaces up to 72 hours.
Akawuka kasobola okubeera ku kintu okumala essaawa 72.
It is most contagious during the first three days after the onset of symptoms, although spread may be possible before symptoms appear and in later stages of the disease.The standard method of diagnosis is by real-time reverse transcription polymerase chain reaction (rRT-PCR) from a nasopharyngeal swab.
Kasinga kusiigibwa mu nnaku ezisooka essatu oluvannyuma lw’okulabika kw’obubonero, wadde ng’okusiigibwa kusoboka okubaawo ng’obubonero tebunneeyoleka ne ku mitendera gy’obulwadde egy’oluvannyuma. Akakodyo akasinga okukozesebwa okubukera ke ka real-time reverse transcription polymerase chain reaction (rRT-PCR) nga baggya oluzzizzi mu mussizo.
The use of masks is recommended for those who suspect they have the virus and their caregivers.
Kisembebwa okukozesa obukookolo ku abo abateebereza nti balina akawuka wamu n’abo ababalabirira.
Recommendations for mask use by the general public vary, with some authorities recommending against their use, some recommending their use, and others requiring their use.
Ebisembebwa mu kukozesa obukookolo mu bantu bonna, ate ng’aboobuyinza abamu babugaana, abamu basemba okubukozesa ate abalala nga bataddewo ekiragiro okubukozesa.
Currently, there is no vaccine or specific antiviral treatment for COVID-19.
Mu kiseera kino, tewali ddagala ligema oba erikkakkanya ku COVID-19.
Local transmission of the disease has been recorded in most countries across all six WHO regions.
Okusaasaana kw’obulwadde munda mu mawanga kulabiddwa mu mawanga mangi ag’enjawulo mu bitundu bya WHO omukaaga.
Those infected with the virus may be asymptomatic or develop flu-like symptoms such as fever, cough, fatigue, and shortness of breath.
Abo abakwatiddwa obulwadde bayinza obuteeyolekerako bubonero oba obutafuna bubonero bwekwanya ku ssenyiga nga omusujja, okukolola, ekimenyoomenyo, n’okukaluubirirwa okussa.
Emergency symptoms include difficulty breathing, persistent chest pain or pressure, confusion, difficulty waking, and bluish face or lips; immediate medical attention is advised if these symptoms are present.
Mu bubonero obw’amangu mulimu okukaluubirirwa mu kussa, okulumizibwa mu kifuba okutatadde oba okunyigirizibwa, okutabukatabuka, okukalemererwa okutambula n’okumyukirira mu maaso oba mu ku mimwa; kyamagezi okufuna obujjanjabi obw’amangu obubonero obwo bwe bugaana okugenda.
Less commonly, upper respiratory symptoms such as sneezing, runny nose or sore throat may be seen.
Obubonero obutatera kulabika mulimu, upper obubonero bw’omussizo ogwawaggulu gamba ng’okukuba emyasi, eminyira egikulukuta oba amabwa mu nnyindo.
Gastrointestinal symptoms such as nausea, vomiting and diarrhoea have been observed in varying percentages.
Obubonero obwekwanya n’omuyungiro gw’olubuto (Gastrointestinal symptoms) gamba nga such as okusinduukirirwa emmeeme, okusesema n’embiro bulabiddwa mu bigero eby’enjawulo.
Some cases in China initially presented only with chest tightness and palpitations.
Mu kusooka, abalwadde abamu mu China basooka kuwulira kuzitoowererwa mu kifuba n’entunnunsi okukubira okumukumu.
In some, the disease may progress to pneumonia, multi-organ failure, and death.
Mu bantu abamu, obulwadde busobola okweyongera okukula ne buvaamu lubyamira, ebitundu by’eomubiri ebiwera okulemererwa okukola, n’okufa.
This is called the incubation period.
Kino kiyitibwa ekiseera ky’okuzaalukana.
The incubation period for COVID-19 is typically five to six days but may range from two to 14 days.
Ekiseera ky’okuzaalukana ekya COVID-19 kiri awo wakati w’ennaku ttaanu n’omukaaga naye nga kisobola okusingawo ne kiba wakati w’ennaku bbiri ne 14.
97.5% of people who develop symptoms will do so within 11.5 days of infection.Reports indicate that not all who are infected develop symptoms.
Abantu ebitundu 97.5% abafuna obubonero, babufuna mu nnaku 11.5 nga bamaze okukwatibwa obulwadde. Alipoota ziraga nti si buli akwatibwa obulwadde nti yeeyolekerako obubonero.
The role of these asymptomatic carriers in transmission is not yet fully known; however, preliminary evidence suggests that they may contribute to the spread of the disease.
Omulimu gw’abo abatalabikirako bubonero mu kusaasaanya obulwadde tegunnaba kumanyika mu bujjuvu; wabula, obubaka obusookerwao bulaga nti basobola okusaasaanya obulwadde.
The proportion of infected people who do not display symptoms is currently unknown and being studied, with the Korea Centers for Disease Control and Prevention (KCDC) reporting that 20% of all confirmed cases remained asymptomatic during their hospital stay.
Ekitungu ky’abantu abalwadde abateeyolekerako bubonero tegumanyiddwa mu kiseera kino era bakyanoonyerezebwako, era ng’Ekitongole kya Korea ekiyitibwa Centers for Disease Control and Prevention (KCDC) kyategeeza nti abalwadde abakakasiddwa ebitundu 20% baali tebeeyolekerako bubonero mu kiseera we baabeerera mu ddwaliro.
China's National Health Commission began including asymptomatic cases in its daily cases on 1 April; of the 166 infections on that day, 130 (78%) were asymptomatic at the time of testing.
Ekitongole kya China ekya National Health Commission kyatandika okubala abalwadde abateeyolekerako bubonero mu balwadde ba buli lunaku nga 1 Ogwokuna; ku balwadde 166 ab’olunaku olwo, abalwadde 130 (78%) tebeeyolekerako bubonero mu kiseera we baabakeberera.
Both sputum and saliva can carry large viral loads.
Ebikolondolwa n’amalusu bisobola okubeeramu obuwuka obuwerera ddala.
Loud talking releases more droplets than normal talking.
Okwogerera waggulu kuleetera omuntu okuvaamu oluzzizzi okusinga okwogera okwabulijjo.
A study in Singapore found that an uncovered cough can lead to droplets travelling up to 4.5 meters (15 feet).
Okunoonyereza mu Singapore kwazuula nti omuntu bw’akolola nga tabisse ku mimwa kumuleetera okuvaamu oluzzizzi olusammukira mu bbanga lya mmita 4.5 (fuuti 15).
Though the virus is not generally airborne, the National Academy of Science has suggested that bioaerosol transmission may be possible and air collectors positioned in the hallway outside of people's rooms yielded samples positive for viral RNA.
Wadde ng’akutwaliza awamu akawuka tekasaasaanira mu mpewo, ekitongole kya National Academy of Science kigamba nti okusaasaana kw’omu mpewo okuyitibwa (bioaerosol transmission) kuyinza okusoboka era obuntu obukwata empewo obwateekebwa ebweru w’amanyumba g’abantu bwavaako sampolo eziraga nti zaalimu RNA.
Some medical procedures such as intubation and cardiopulmonary resuscitation (CPR) may cause respiratory secretions to be aerosolised and thus result in airborne spread.
Emitendera gy’eddagala egimu gamba nga intubation ne cardiopulmonary resuscitation (CPR) giyinza okubaamu obuntu obuva mu missizo obusaasaanyizibwa mu pewo bwe butyo ne buvaamu endwadde ezisaasaanyirizibwa mu mpewo.
While there are concerns it may spread via feces, this risk is believed to be low.The virus is most contagious when people are symptomatic; while spread may be possible before symptoms emerge, the risk is low.
Weewaawo waliwo okutya nti obulwadde buyinza okusaasaana nga buyitira mu bubi, obulabe bwa kino bulowoozebwa okuba obutono. Akawuka kasinga kukwata ng’abalwadde beeyolekerako obubonero; wadde ng’okusiiga kusoboa ng’obubonero tebuneeyoleka, obulabe bwa kino butono.
The European Centre for Disease Prevention and Control (ECDC) says while it is not entirely clear how easily the disease spreads, one person generally infects two to three others.The virus survives for hours to days on surfaces.
Ekitongol kya Bulaaya ekirwanyisa endwadde ekiyitibwa European Centre for Disease Prevention and Control (ECDC) kigamba nti wadde nga tekitangala bulungi ku bwangu endwadde kw’esaasaanira, okutwaliza awamu, omuntu omu asiiga abantu babiri oba basatu abalala. Akawuka kamala ebbanga eriri wakati w’essaawa n’ennaku nga kali kungulu ku bintu.
Specifically, the virus was found to be detectable for one day on cardboard, for up to three days on plastic (polypropylene) and stainless steel (AISI 304), and for up to four hours on 99% copper.
Okusinga ennyo, akawuka kalabiddwa nga kasobola okukengebwa nga kamaze olunaku lumu ku kabada, n’ennaku ssatu ku pulasitiika (polypropylene) ne ku bintu ebitatalagga (AISI 304), ate n’okumala essaawa nnya ku bintu ebirimu kkopa aweza ebitundu 99%.
This, however, varies depending on the humidity and temperature.
Wabula, ebbanga lino lyawuka okusinziira ku luzzi oluli mu bbanga n’ebbugumu.
Soap and detergent are also effective if correctly used; soap products degrade the virus' fatty protective layer, deactivating it, as well as freeing them from skin and other surfaces.
Ssabbuuni n’ebirungo ebirongoosa (detergent) nabyo bikola bulungi bwe bikozesebwa obulungi; ebintu ebirimu ssabbuuni bitta olususu lw’akawuka olukakuuma, bikamalamu amaanyi era bikaggyako olukuta lwonna n’okubugoba ku bintu ebirala.
Other solutions, such as benzalkonium chloride and chlorhexidine gluconate (a surgical disinfectant), are less effective.In a Hong Kong study, saliva samples were taken a median of two days after the start of hospitalization.
Ebintu ebirala ebiyiika nga benzalkonium chloride ne chlorhexidine gluconate (ekirungo ekitta obuwuka ekikozesebwa mu kulongoosa abantu), tebikola bulungi. Mu kunoonyereza okwakolebwa mu Hong Kong, sampolo z’amalusu zaggyibwa ku bantu mu kigero ky’ennaku nga bbiri nga bamaze okuweebwa ebitanda.
In five of six patients, the first sample showed the highest viral load, and the sixth patient showed the highest viral load on the second day tested.
Ku balwadde abantu ku mukaaga, sampolo eyasooka yalaga nti erimu obuwuka bungi ate omulwadde owoomukaaga yalabika ng’alina obuwuka bungi ku lunaku olwokubiri lwe yakeberwa.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel severe acute respiratory syndrome coronavirus, first isolated from three people with pneumonia connected to the cluster of acute respiratory illness cases in Wuhan.
Akawka ka Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) kawuka ka akakosa omussizo akayitibwa novel severe acute respiratory syndrome coronavirus, akaasooka okulabibwa mu bantu basatu abaalina lubyamira nga yeekwanya ku bulwadde obw’amaanyi obukosa omussizo obwalabibwa mu balwadde mu Wuhan.
All features of the novel SARS-CoV-2 virus occur in related coronaviruses in nature.
Obubonero bwonna obwa novel SARS-CoV-2 virus bujjawo mu buwuka bwonna obwekwanya ne coronaviruses mu kikula.
Outside the human body, the virus is killed by household soap, which bursts its protective bubble.SARS-CoV-2 is closely related to the original SARS-CoV.
Akawuka ako bwe kabeera ebweru w’omubiri gw’omuntu gaka nga kakwataganye ssabbuuni, ssabbuuni abalusa olwovuyovu lw’akawuka olukabeera ebweru. SARS-CoV-2 kakwatagana bulungi n’akawuka ka SARS-CoV akaasooka.
The lungs are the organs most affected by COVID-19 because the virus accesses host cells via the enzyme angiotensin-converting enzyme 2 (ACE2), which is most abundant in the type II alveolar cells of the lungs.
Amawuggwe ge gasinga okukosebwa COVID-19 kubanga akawuka kayingira mu butaffaali nga kayitira mu enzyme angiotensin-converting enzyme 2 (ACE2), akasinga okulabikira mu type II alveolar cells mu mawuggwe.
The virus uses a special surface glycoprotein called a "spike" (peplomer) to connect to ACE2 and enter the host cell.
Akawuka kakozesa olususu olw’enjawulo olwa glycoprotein oluyitibwa "eriggwa" (peplomer) okweyunga ku ACE2 ne kayingir amu kataffaali kwe keekwata.
Acute cardiac injury was found in 12% of infected people admitted in hospital in Wuhan, China, and is more frequent in severe disease.
Okukosebwa kw’omutima okw’amaanyi kwasangibwa mu balwadde ebitundu 12% abaaweebwa ebitanda mu Wuhan, China, era kalabika nnyo mu ndwadde ez’amaanyi.
Rates of cardiovascular symptoms is high, owing to the systemic inflammatory response and immune system disorders during disease progression, but acute myocardial injury may also be related to ACE2 receptors in the heart.
Ekigero ky’obubonero obwekwanya ku mutima n’emisiwa (cardiovascular symptoms) kiri waggulu, nga kiva ku systemic inflammatory response n’obuzibu mu muyungiro gw’obusibage mu kiseera ky’okweyongera kw’obulwadde, naye acute myocardial injury buyinza nabwo okuba nga bwekwanya ku ACE2 receptors mu mutima.
ACE2 receptors are highly expressed in the heart and are involved in heart function.
ACE2 receptors zirabikira nnyo mu mutima era zeetaba mu nkola y’omutima.
A high incidence of thrombosis (31%) and venous thromboembolism (25%) have been found in ICU patients with COVID-19 infections and may be related to poor prognosis.Autopsies of people who died of COVID-19 have found diffuse alveolar damage (DAD), and lymphocyte-containing inflammatory infiltrates within the lung.
ekizibu ky’okwekwata kw’omusaayi (31%) n’okuzibikira kw’emisiwa (venous thromboembolism) (25%) bisangiddwa mu balwadde ba COVID-19 abeetaaga abujjanjabi obw’enjawulo abalina era nga buyinza okuba nga bwekwanya ku nteebereza enkyamu. Okukebera emirambo gy’abantu abafudde COVID-19 kuzudde diffuse alveolar damage (DAD), n’obusibage bw’obutaffaali omuli omusaayi ogwekutt mu mawuggwe.
Although SARS-COV-2 has a tropism for ACE2-expressing epithelial cells of the respiratory tract, patients with severe COVID-19 have symptoms of systemic hyperinflammation.
Newankubadde nga SARS-COV-2 atambulira ku kusikirizibwa kwa ACE2-omuli epithelial cells ez’omussizo, abalwadde ba COVID-19 abayi balina obubonero bwa systemic hyperinflammation.
In particular, pathogenic GM-CSF-secreting T-cells were shown to correlate with the recruitment of inflammatory IL-6-secreting monocytes and severe lung pathology in COVID-19 patients.
Okusinga ennyo, pathogenic GM-CSF-secreting T-cells zaalagibwa okuba nga zikwatagana ne inflammatory IL-6-secreting monocytes ne severe lung pathology mu balwadde ba COVID-19.
Lymphocytic infiltrates have also been reported at autopsy.
Obukulungwa obwekwafu (Lymphocytic infiltrates) bulabiddwako mu kukebera emirambo egifudde.
The WHO has published several testing protocols for the disease.
WHO kifulumiza enseetuka y’okunoonyereza ku bulwadde buno nnyingi.
The standard method of testing is real-time reverse transcription polymerase chain reaction (rRT-PCR).
Okukbera okwa bulijjo kwe kwa real-time reverse transcription polymerase chain reaction (rRT-PCR).
The test is typically done on respiratory samples obtained by a nasopharyngeal swab; however, a nasal swab or sputum sample may also be used.
Okukebera kuno kutera kukolebwa ku sampolo eziggyibwa mu mussizo era nga zifunibwa ne swab ey’omu mussizo; wabula swab ey’omu nnyindo oba ekikolondolwa nabyo bisobola okukozesebwa.
Results are generally available within a few hours to two days.
Ebivaamu bitera okufunibwa mu bbanga eriri wakati w’essaaawa entonotono n’ennaku bbiri.
Blood tests can be used, but these require two blood samples taken two weeks apart and the results have little immediate value.
Okukebera omusaayo nakwo kusobola okukozesebwa naye sampolo ezo zirina okubeera bbiri nga ziggyibwa ku muntu mu bbanga lya wiiki bbiri ezeesudde era ebivaamu tebitera kugasa mu kaseera ak’amangu.
Chinese scientists were able to isolate a strain of the coronavirus and publish the genetic sequence so laboratories across the world could independently develop polymerase chain reaction (PCR) tests to detect infection by the virus.
Bannassaayansi b’e China baalengera obulwadde bwa coronavirus era ne bafulumya ebikwata ku bulwadde obwo (genetic sequence) olwo amagezeserezo mu nsi yonna ne gaba nga gasobola, kinnalimu okukola ku nteekateeka y’okukebera obulwadde bw’akawuka ako (polymerase chain reaction) (PCR).
As of 4 April 2020, antibody tests (which may detect active infections and whether a person had been infected in the past) were in development, but not yet widely used.
Nga 4 Ogwokuna 2020, okukebera abasirikale b’omubiri (okusobola okukenga obulwadde obuli mu mubiri n’oba ng’omuntu yabadde alwadde emabegako) kwali mu nkulaakulanya, naye nga kwali tekunnaba kukozesebwa wonna.
The Chinese experience with testing has shown the accuracy is only 60 to 70%.
Obumanyirivu bw’okukebera mu China bulaze nti obutuufu bw’okukbera wakati w’ebitundu 60 okutuuka ku 70% byokka.
The FDA in the United States approved the first point-of-care test on 21 March 2020 for use at the end of that month.Diagnostic guidelines released by Zhongnan Hospital of Wuhan University suggested methods for detecting infections based upon clinical features and epidemiological risk.
Ekitongole kya FDA mu Amerika kyayisa okukebera okw’amangu okukolebwa ku mulwadde (first point-of-care test) okukozesebwa nga 21 Ogwokusatu 2020 ku nkomerero y’omwezi ogwo. Ebigobererwa mu kukebera ebyafulumizibwa eddwaliro Zhongnan Hospital mu Wuhan University byalimu okuteesa obukodyo obw’okukenga obulwadde nga bwesigamiziddwa ku bubonero n’obulabe obw’engeri y’okunoonyereza ku bulwadde(features and epidemiological risk).
Bilateral multilobar ground-glass opacities with a peripheral, asymmetric and posterior distribution are common in early infection.
Bilateral multilobar ground-glass opacities with a peripheral, asymmetric and posterior distribution are common in early infection.
Subpleural dominance, crazy paving (lobular septal thickening with variable alveolar filling), and consolidation may appear as the disease progresses.
Bino biyinza okubaawo ng’obulwadde bugenda bukula Subpleural dominance, crazy paving (lobular septal thickening with variable alveolar filling), ne consolidation.
Few data are available about microscopic lesions and the pathophysiology of COVID-19.
Obubaka butono obuliwo ku bizimbulukusa (microscopic lesions) ne pathophysiology of COVID-19 butono ddala.
The main pathological findings at autopsy are:
Ebizuuliddwa ebikulu mu kukebera abantu abafudde bye bino:
Macroscopy: pleurisy, pericarditis, lung consolidation and pulmonary oedema
Macroscopy: pleurisy, pericarditis, lung consolidation ne pulmonary oedema
Four types of severity of viral pneumonia can be observed:
Ebika bina ebikambwe ebya lubyamira asaasanyizibwa akawuka bye bisobola okwekkenneenyezebwa:
mild pneumonia: pulmonary oedema, pneumocyte hyperplasia, large atypical pneumocytes, interstitial inflammation with lymphocytic infiltration and multinucleated giant cell formation
lubyamira atali wa maanyi: pulmonary oedema, pneumocyte hyperplasia, large atypical pneumocytes, interstitial inflammation with lymphocytic infiltration ne multinucleated giant cell formation
severe pneumonia: diffuse alveolar damage (DAD) with diffuse alveolar exudates.
lubyamira omukambwe: diffuse alveolar damage (DAD) ne diffuse alveolar exudates.
DAD is the cause of acute respiratory distress syndrome (ARDS) and severe hypoxemia.
DAD y’aleeta obuzibu obw’amaanyi mu kussa “acute respiratory distress syndrome (ARDS)” ne hypoxemia ow’amaanyi.
healing pneumonia: organisation of exudates in alveolar cavities and pulmonary interstitial fibrosis
okuwonya lubyamira: oba enteekateeka y’ebiva mu bibuno by’ebijijo ne pulmonary interstitial fibrosis
Blood: disseminated intravascular coagulation (DIC); leukoerythroblastic reaction
Omusaayi: disseminated intravascular coagulation (DIC); leukoerythroblastic reaction
Preventive measures to reduce the chances of infection include staying at home, avoiding crowded places, washing hands with soap and water often and for at least 20 seconds, practising good respiratory hygiene and avoiding touching the eyes, nose or mouth with unwashed hands.
Ebikolebwa okukendeeza ku mikisa gy’okusiigibwa mulimu okubeera ewaka, okwewala ebifo ebirimu abantu abanti, okunaaba mu ngalo ne ssabbuuni n’amazzi emirundi egiwera okumala waakiri sekonda 20, okweyisa mu ngeri ennyonjo ku by’engeri y’okussa n’okwewaka okukwata mu maaso, ennyindo oba mu kamwa nga tonnanaaba mu ngalo.
The CDC recommends covering the mouth and nose with a tissue when coughing or sneezing and recommends using the inside of the elbow if no tissue is available.
Ekitongole kya CDC kisemba okubikka ku mimwa n’ennyindo n’akagoye buli lw’obeera ng’okolola oba okukuba emyasi era kisemba okufunya omukono n’oyasimula oba okukolola bw’oba nga tolina kagoye.
Proper hand hygiene after any cough or sneeze is encouraged.
Okuyonja engalo obulungi engalo ng’omaze okukolola oba okukuba emyasi kisembebwa.
The CDC has recommended the use of cloth face coverings in public settings, in part to limit transmission by asymptomatic individuals.Social distancing strategies aim to reduce contact of infected persons with large groups by closing schools and workplaces, restricting travel and cancelling large public gatherings.
Ekitongole kya CDC kisemba okukozesa akagoye akabikka ku maaso ng’omuntu ali mu lujjudde, ekigendererwa ekimu mu kino kwe kwewala okusiiga obulwadde naddala ku balwadde abaneeyolekerako bubonero. Obukodyo bw’okwewa amabanga bugenderera okukendeeza ku kukwatagana kw’abantu abalina obulwadde n’ebibinja by’abantu ebinene ng’amasomero gaggalwa n’ebifo ebikolerwamu, okukugira okutambula n’okusazaamu enkuŋŋaana z’abantu abanti.
Distancing guidelines also include that people stay at least 6 feet (1.8 m) apart.
Ebigobererwa by’okwewa amabanga era bizingiramu n’okuba nti abantu beesuula waakiti fuuti 6 (1.8 m).
There is no medication known to be effective at preventing COVID-19.As a vaccine is not expected until 2021 at the earliest, a key part of managing COVID-19 is trying to decrease the epidemic peak, known as "flattening the curve".
Tewali ddagala limanyiddwa nga liziyiza COVID-19. Ekiseera eky’amangu eddagala erigema we lisuubirirwa okulabika, kiri mu mwaka gwa 2021, akakodyo ak’okulwanyisa COVID-19 kwe kugezaako okukendeeza okutumbiira kw’obulwadde, ekiyitibwa "okuseeteeza akoole".
The CDC also recommends that individuals wash hands often with soap and water for at least 20 seconds, especially after going to the toilet or when hands are visibly dirty, before eating and after blowing one's nose, coughing or sneezing.
Ekitongole kya CDC era kyasemba abantu kinnoomu okunaaba engalo ne ssabbuuni n’amazzi okumala waakiri sekonda 20, naddala nga bavudde mu kaabuyonjo oba ng’engalo zirabikira ddala nti ziddugala, nga tebannaba kulya ne nga bamaze okunyiza, okukolola oba okwasimulaalso.
It further recommends using an alcohol-based hand sanitiser with at least 60% alcohol, but only when soap and water are not readily available.For areas where commercial hand sanitisers are not readily available, the WHO provides two formulations for local production.
Ekitongole era kisemba okukozesa sanitizer alimu omwenge oguwera waakiri ebitundu 60%, naye ng’ekyo bakikola nga waakiri sabbuuni n’amazzi tebiriiwo. Mu bitundu ebitaliimu sanitizer zitundibwa, ekitongole kya WHO kiwa amagezi ga mirundi ebiri ku ngeri gye ziyinza okukolebwa.
In these formulations, the antimicrobial activity arises from ethanol or isopropanol.
Mu kukola batyo, enkola y’eddagala eritta obuwuka liva mu mwenge (ethanol) oba isopropanol.
Hydrogen peroxide is used to help eliminate bacterial spores in the alcohol; it is "not an active substance for hand antisepsis".
Hydrogen peroxide akozesebwa okuyambako okumalawo bacterial spores mu mwenge; si "kirungo ekikola okutta obuwuka mu ngalo (hand antisepsis)".
Glycerol is added as a humectant.
Glycerol ateekebwamu okuvaamu oluzzizzi (humectant.
People are managed with supportive care, which may include fluid therapy, oxygen support, and supporting other affected vital organs.
Abantu bakolebwamu na bujjanjabi obubawanirira, obuyinza okuzingiramu, amazzi, okuteekebwako omukka (oxygen), n’okuwanirira ebitundu by’omubiri ebiba bikoseddwa.
The CDC recommends that those who suspect they carry the virus wear a simple face mask.
Ekitongole kya CDC kisemba nti abo abateebereza nti balina akawuka, bambale akakookolo akangungu.
Extracorporeal membrane oxygenation (ECMO) has been used to address the issue of respiratory failure, but its benefits are still under consideration.
Okuteekebwako omukka (Extracorporeal membrane oxygenation, ECMO) kukozeseddwa okukola ku kizibu ky’okulemererwa okussa naye ng’emiganyulo gy’enkola eno gikyatunuulirwa.
Personal hygiene and a healthy lifestyle and diet have been recommended to improve immunity.
Obuyonjo obw’omuntu kinnoomu n’okwefaako mu byobulamu n’okulya emmere erimu ebiriisa ey’enjawulo bisembebwa okwongera ku busibage bw’omuntu.
Supportive treatments may be useful in those with mild symptoms at the early stage of infection.The WHO and Chinese National Health Commission have published recommendations for taking care of people who are hospitalised with COVID-19.
Obujjanjabi obuwanirizi buyinza okuyamba abo abalina obubonero obutali bwa maanyi ng’obulwadde bwakabakwata. WHO ne Chinese National Health Commission bafulumizza ebisembebwa okujjanjaba abantu abaweereddwa ebitanda nga balina COVID-19.
Intensivists and pulmonologists in the U.S. have compiled treatment recommendations from various agencies into a free resource, the IBCC.
Abasawo abalabirira abalwadde abayi (Intensivists) n’abasawo abajjanjaba emissizo (pulmonologists) mu Amerika bawandiise ebyokukola ebisembebwa okuva mu bitongole eby’enjawulo ne babiteeka mu kiwandiiko ekyobwereere, IBCC.
As of April 2020, there is no specific treatment for COVID-19.
Mu Gwokuna 2020, tewali bujjanjabi bwa COVID-19 bwatuukiddwako.
For symptoms, some medical professionals recommend paracetamol (acetaminophen) over ibuprofen for first-line use.
Mu kujjanjaba obubonero, abakugu abamu basemba okukozesa paracetamol (acetaminophen) over ibuprofen ng’eddagala erisookerwako.